CClinicalTrials.gg
CompletedNCT02379013FATIGUEUpdated Feb 13, 2017

Measure of Fatigue in Functional MRI

An interventional study of Volunteer with MRI in Fatigue, sponsored by Hôpital NOVO. Completed. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-02-13.

Sponsored by Hôpital NOVO · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
37
Allocation
Not applicable
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The purpose of this study is to determine more objective, central and peripheral indices of fatigue state by exploring the neural and behavioral correlates of the alert process while keeping the idea to corroborate these results with those obtained during the performance of physical exercises and neuropsychological tests "classics" of attention, motivation, and functions evaluation. The interest of this study is to manipulate and compare the phasic and tonic alert mechanism through the activation of an extrinsic motivational system during fatigue. The investigators have chosen the alert since it is a basic cognitive process defined as the ability to increase attentional resources with the expectation of a target stimulus resulting in reduced response time. It can be phasic (extrinsic), favored by the presence of a warning signal preceding the target (preparation time) or tonic (intrinsic) occurring without warning signal (wakefulness). The evaluation of the alert is classically realized by a simple reaction time task with the presence or not of warning signal soliciting wether the tonic alert or the phasic alert.

The investigators suppose to revisit the healthy population with brain model alert issued in 2010 which highlighted the predominant role of the regions of the dorsolateral prefrontal cortex, parietal, cingulate and thalamus (non-motor) in maintaining attention and temporal preparation alert task.

The investigators identify also functional, motor and cognitive components of basal ganglia of thalamus. Cognitive-motor paradigm and neurological dysfunctions observed in multiple sclerosis population will help to identify and separate the cognitive role and motor brain regions, particularly the thalamus and basal ganglia. New neurological hypotheses are proposed

Read the detailed description

This project will be applied on healthy subjects, and the subject will be equipped with two electrodes attached to the muscle of the left arm (flexor) to measure muscle activity. That will be performed with a handgrip (the subject press on the handgrip).The subject will receive two sessions. It will conduct a trial session in the laboratory to control his ability to imagine the task (imagination run) and perform the driving task correctly.

Two saliva samples will be placed in tubes to be analysed to measure the concentration of cortisol before and after functional MRI. Then, psychological and satisfaction questionnaires will be completed by volunteers.

This protocol will then be adapted and transferred to multiple sclerosis population (in a second study), for which fatigue is one of the symptoms most commonly reported.

02

Conditions studied

  • Fatigue

Browse trials for

Keywords

  • Fatigue
  • functional MRI
03

In context

Fatigue

1,860 studies on the registry are indexed under Fatigue; 376 are open to participants now.

This study's enrollment of 37 is below the median of 54 across 1,440 interventional studies indexed under Fatigue.

Browse Fatigue studies →

Lead sponsor

Hôpital NOVO is the lead sponsor of 69 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male or female right-handed aged between 18 and 35 years
  • Free of neurological, psychiatric or abuse of alcohol or drugs
  • Affiliated with the social security system (beneficiary or legal)
  • Having understood the information and having signed the consent form

Exclusion criteria

Exclusion Criteria:

  • Against indication to 'MRI': Pacemaker or neurosensory pacemaker or implantable defibrillator, cochlear implants, Ocular or cerebral ferromagnetic foreign body near the nerve structures, metal prosthesis, Ventriculoperitoneal shunt valves neurosurgical, brace, Agitation of the patient: not cooperating or agitated subjects, low-age children, claustrophobic patient, expectant mother
  • Front-temporal dementia
  • Physical or psychiatric illness likely to interfere with the functional assessment
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
37 participants (actual)

Study arms

  • Experimental
    Volunteer with MRI

    All volunteer will be included in the arm MRI

    Procedure: Volunteer with MRI

Interventions

  • ProcedureVolunteer with MRI

    functional MRI

06

What researchers measure

Primary outcomes

  1. Assessment of executive function and circuit of functional MRI

    Brain activity will be measured during tests to determine the central indices and peripheral quantitative and objectives of the state of fatigue.

    Time frame: 1 day

Secondary outcomes

  1. Muscle strength measured with the electromyogram data

    This outcome will be measured with the electromyogram data

    Time frame: 1 day

  2. Saliva samples to measure the concentration of cortisol

    Samples will be placed in tubes to be analysed to measure the concentration of cortisol.

    Time frame: 1 day

  3. Assess attentional and executive functions (questionnaires)

    Results of psychological (Mesulam, D2, Stroop) questionnaires

    Time frame: 1 day

  4. Evaluation of voluntary satisfaction (questionnaire)

    satisfaction questionnaire

    Time frame: 1 day

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 13, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02379013
Lead sponsor
Hôpital NOVO
Collaborators
Paris West University Nanterre La Défense
Responsible party
Sponsor
First posted
Mar 4, 2015
Start date
Feb 2015
Primary completion
Nov 2015
Completion
Nov 2015
Last update
Feb 13, 2017

Study contacts

Alain LE BLANCHE, PUPH
principal investigator · Hôpital NOVO

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion